Biogen update on European Spinraza access

Whilst the process for determining whether Spinraza will be funded in England continues, Biogen, the manufacturer, issued a community announcement with updates as to availability across Europe, which can be read here.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.